MICILLO, MATILDE
MICILLO, MATILDE
SCIENZE MEDICHE
A molecular circuit linking the BCR to the NAD biosynthetic enzyme NAMPT is an actionable target in Richter syndrome
2024-01-01 Messana V.G.; Fasci A.; Vitale N.; Micillo M.; Rovere M.; Pesce N.A.; Martines C.; Efremov D.G.; Vaisitti T.; Deaglio S.
Anti-CD37 α-amanitin–conjugated antibodies as potential therapeutic weapons for Richter syndrome
2022-01-01 Vaisitti T.; Vitale N.; Micillo M.; Brandimarte L.; Iannello A.; Papotti M.G.; Jaksic O.; Lopez G.; Di Napoli A.; Cutrin J.C.; Orlik C.; Kulke M.; Pahl A.; Deaglio S.
Antibody–Drug Conjugates in Hematological Malignancies: Current Landscape and Future Perspectives
2026-01-01 Maria Chiara Montalbano, Matilde Micillo, Silvia Deaglio, Tiziana Vaisitti
Common genomic and transcriptomic signatures in Richter transformation highlight druggable vulnerabilities and guide drug repurposing strategies
2026-01-01 Vallone F.E.; Omezzolli G.; Micillo M.; Iannello A.; Ferrero G.; Berrino E.; Mereu E.; Bellomo S.E.; Rosso E.; Di Napoli A.; Jaksic O.; Molinaro L.; Marchio C.; Piva R.; Cordero F.; Deaglio S.; Vaisitti T.
Complementary approaches define the metabolic features that accompany Richter syndrome transformation
2025-01-01 Omezzolli, Giulia; Iannello, Andrea; Vallone, Francesco E; Brandimarte, Lorenzo; Micillo, Matilde; Bertola, Nadia; Lavarello, Chiara; Grinovero, Nicole; Ferrero, Giulio; Mellert, Kevin; Möller, Peter; Bruno, Silvia; Furman, Richard R; Allan, John N; Petretto, Andrea; Deaglio, Silvia; Ravera, Silvia; Vaisitti, Tiziana
Decreased apoptotic priming and loss of BCL-2 dependence are functional hallmarks of Richter’s syndrome
2024-01-01 Rigo, Antonella; Vaisitti, Tiziana; Laudanna, Carlo; Terrabuio, Eleonora; Micillo, Matilde; Frusteri, Cristina; D'Ulivo, Beatrice; Merigo, Flavia; Sbarbati, Andrea; Mellert, Kevin; Möeller, Peter; Montresor, Alessio; Di Napoli, Arianna; Cirombella, Roberto; Butturini, Elena; Massaia, Massimo; Constantin, Gabriela; Vinante, Fabrizio; Deaglio, Silvia; Ferrarini, Isacco
Targeting RYK with the novel antibody drug conjugate SLV 404 is effective in Richter transformation patient derived xenografts
2026-05-18
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A molecular circuit linking the BCR to the NAD biosynthetic enzyme NAMPT is an actionable target in Richter syndrome | 2024 | Messana V.G.; Fasci A.; Vitale N.; Micillo M.; Rovere M.; Pesce N.A.; Martines C.; Efremov D.G.; Vaisitti T.; Deaglio S. | |
| Anti-CD37 α-amanitin–conjugated antibodies as potential therapeutic weapons for Richter syndrome | 2022 | Vaisitti T.; Vitale N.; Micillo M.; Brandimarte L.; Iannello A.; Papotti M.G.; Jaksic O.; Lopez G.; Di Napoli A.; Cutrin J.C.; Orlik C.; Kulke M.; Pahl A.; Deaglio S. | |
| Antibody–Drug Conjugates in Hematological Malignancies: Current Landscape and Future Perspectives | 2026 | Maria Chiara Montalbano, Matilde Micillo, Silvia Deaglio, Tiziana Vaisitti | |
| Common genomic and transcriptomic signatures in Richter transformation highlight druggable vulnerabilities and guide drug repurposing strategies | 2026 | Vallone F.E.; Omezzolli G.; Micillo M.; Iannello A.; Ferrero G.; Berrino E.; Mereu E.; Bellomo S.E.; Rosso E.; Di Napoli A.; Jaksic O.; Molinaro L.; Marchio C.; Piva R.; Cordero F.; Deaglio S.; Vaisitti T. | |
| Complementary approaches define the metabolic features that accompany Richter syndrome transformation | 2025 | Omezzolli, Giulia; Iannello, Andrea; Vallone, Francesco E; Brandimarte, Lorenzo; Micillo, Matilde; Bertola, Nadia; Lavarello, Chiara; Grinovero, Nicole; Ferrero, Giulio; Mellert, Kevin; Möller, Peter; Bruno, Silvia; Furman, Richard R; Allan, John N; Petretto, Andrea; Deaglio, Silvia; Ravera, Silvia; Vaisitti, Tiziana | |
| Decreased apoptotic priming and loss of BCL-2 dependence are functional hallmarks of Richter’s syndrome | 2024 | Rigo, Antonella; Vaisitti, Tiziana; Laudanna, Carlo; Terrabuio, Eleonora; Micillo, Matilde; Frusteri, Cristina; D'Ulivo, Beatrice; Merigo, Flavia; Sbarbati, Andrea; Mellert, Kevin; Möeller, Peter; Montresor, Alessio; Di Napoli, Arianna; Cirombella, Roberto; Butturini, Elena; Massaia, Massimo; Constantin, Gabriela; Vinante, Fabrizio; Deaglio, Silvia; Ferrarini, Isacco | |
| Targeting RYK with the novel antibody drug conjugate SLV 404 is effective in Richter transformation patient derived xenografts | 2026 | - |